Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00129597 |
Recruitment Status : Unknown
Verified March 2007 by Hospices Civils de Lyon.
Recruitment status was: Active, not recruiting
First Posted : August 12, 2005
Last Update Posted : March 12, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain Breast Cancer | Drug: ketalar | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy |
Study Start Date : | December 2004 |

- To evaluate the effect of perioperative ketalar on pain intensity 3 months after a mastectomy
- Pain intensity is evaluated by an appropriate questionnaire 1 and 3 months after surgery.
- To evaluate the incidence of chronic pain after mastectomy, the impact on life quality, and the area of hyperalgesia

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Mastectomy in patients 18 to 80 years old
Exclusion Criteria:
- American Society of Anesthesiology (ASA) class >= 3
- Renal, heart or hepatic failure
- Allergy to ketalar
- Psychiatric disease
- Chronic antalgic treatment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00129597
France | |
Centre Hospitalier Lyon Sud | |
Pierre bénite, France, 69495 |
Principal Investigator: | Vincent PIRIOU, MD | Hospices Civils de Lyon |
ClinicalTrials.gov Identifier: | NCT00129597 |
Other Study ID Numbers: |
2004.349 |
First Posted: | August 12, 2005 Key Record Dates |
Last Update Posted: | March 12, 2007 |
Last Verified: | March 2007 |
Ketalar NMDA mastectomy postoperative chronic pain Chronic pain after mastectomy for breast cancer |
Chronic Pain Pain Neurologic Manifestations Ketamine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anesthetics, Dissociative |
Anesthetics, Intravenous Anesthetics, General Anesthetics Central Nervous System Depressants Excitatory Amino Acid Antagonists Excitatory Amino Acid Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |